This is Replicor Inc's Typepad Profile.
Join Typepad and start following Replicor Inc's activity
Join Now!
Already a member? Sign In
Replicor Inc
Montreal, Quebec
Replicor Inc is a clinical-stage drug company developing novel Nucleai Acid-Based Polymers (NAPs) as a cure for the Hepatitis B Virus and the Hepatitis D Virus. Clinical trials to date have been highly encouraging.
Interests: hepatitis b, drugs, cure, hapatitis
Recent Activity
Replicor Inc is now following The Typepad Team
Mar 29, 2015